Hi Tony,
The article Excited about Cycling provides excellent context in relation to the points which you have made about macrocycles;
"Natural macrocycles are chemically complex and difficult to synthesize, which has prevented the large-scale synthesis of compound libraries."
What is the advantage of natural macrocycles?
"The clinical successes of macrocyclic natural products [like the fungal-derived cyclosporine] provide tantalizing hints of what could be achieved by the systematic exploration of this compound class."
What if Phylogica could harness natural products and create large-scale synthetic libraries? Perhaps this is exactly what they have been able to achieve. From the Annual Report for 2013;
"[Efforts include the generation of] genetically encoded macrocyclic phylomer libraries that promise to significantly improve the drug-like properties of hits that emerge from the various screens."
Wayne.
- Forums
- ASX - By Stock
- PYC
- targeting intracellular proteins
PYC
pyc therapeutics limited
Add to My Watchlist
2.21%
!
$1.39

targeting intracellular proteins, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.39 |
Change
0.030(2.21%) |
Mkt cap ! $810.7M |
Open | High | Low | Value | Volume |
$1.39 | $1.39 | $1.33 | $103.4K | 75.90K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2600 | $1.37 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.39 | 14999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2600 | 1.365 |
1 | 2235 | 1.340 |
1 | 2000 | 1.320 |
1 | 6000 | 1.310 |
1 | 1000 | 1.300 |
Price($) | Vol. | No. |
---|---|---|
1.390 | 14999 | 1 |
1.400 | 18200 | 2 |
1.410 | 15800 | 2 |
1.420 | 500 | 1 |
1.440 | 4000 | 1 |
Last trade - 16.10pm 21/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |